200,000+ products from a single source!
sales@angenechem.com
CAS No: 10198-83-1 Catalog No: AG000669 MDL No:
Title | Journal |
---|---|
Orally available pyridinylpyrimidine derivatives as novel RANKL-induced osteoclastogenesis inhibitors. | Bioorganic & medicinal chemistry letters 20120901 |
A novel inhibitor of hypoxia-inducible factor-1α P3155 also modulates PI3K pathway and inhibits growth of prostate cancer cells. | BMC cancer 20110101 |
Development of novel inhibitors targeting HIF-1α towards anticancer drug discovery. | Bioorganic & medicinal chemistry letters 20101115 |
Discovery of a potent, selective, and orally bioavailable pyridinyl-pyrimidine phthalazine aurora kinase inhibitor. | Journal of medicinal chemistry 20100909 |
A single molecular system gating electron transfer by ring inversion of a methylpyridylpyrimidine ligand on copper. | Journal of the American Chemical Society 20090325 |
The structure of the leukemia drug imatinib bound to human quinone reductase 2 (NQO2). | BMC structural biology 20090101 |
Evolution of a highly selective and potent 2-(pyridin-2-yl)-1,3,5-triazine Tie-2 kinase inhibitor. | Journal of medicinal chemistry 20070222 |
From imidazoles to pyrimidines: new inhibitors of cytokine release. | Journal of medicinal chemistry 20020620 |
© 2019 Angene International Limited. All rights Reserved.